<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.PatentFamilySummaryOutputs xmlns:ns2="local"><PatentFamilySummaryOutput id="1754169"><Title>Preparation of a quinolinyloxydiphenylcyclopropanedicarboxamide</Title><Assignee>Glaxosmithkline Llc</Assignee><Familymembers>WO-2010036831; AR-00075084; CN-102227164; EP-02339918; JP-05587324; TW-201035017; US-08314232; UY-00032142</Familymembers><PatentNumber>WO-2010036831</PatentNumber><Indication>Stomach tumor; Renal cell carcinoma; Liver tumor; Head and neck tumor; Solid tumor</Indication><Action>Flt3 tyrosine kinase inhibitor; VEGF-2 receptor antagonist; Kit tyrosine kinase inhibitor; Tek tyrosine kinase receptor inhibitor</Action></PatentFamilySummaryOutput></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.PatentFamilySummaryOutputs>